This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Is Invesco S&P 100 Equal Weight ETF (EQWL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EQWL
Is Invesco S&P 500 Equal Weight ETF (RSP) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSP
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
Should Invesco S&P 500 Equal Weight ETF (RSP) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RSP
UnitedHealth Group's (UNH) Brazil Unit Draws Buyout Interests
by Zacks Equity Research
UnitedHealth Group (UNH) expects to divest its troubled Brazil business, enhancing its overall results.
The Zacks Analyst Blog Highlights UnitedHealth, Humana, Centene and Molina Healthcare
by Zacks Equity Research
UnitedHealth, Humana, Centene and Molina Healthcare are included in this Analyst Blog.
4 Health Insurers Likely to Maintain Winning Streak in 2024
by Debasmita Chatterjee
Medical-HMO stocks like UNH, HUM, CNC and MOH are expected to reap the benefits of an aging U.S. population and growing premiums in 2024. However, challenges related to the resumption of elective procedures might play spoilsport.
Here's Why UnitedHealth Group (UNH) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $526.55, marking a -0.86% move from the previous day.
UnitedHealth Group's (UNH) Arm Launches OptumRx Weight Engage
by Zacks Equity Research
UnitedHealth Group (UNH) enhances Optum Rx's offerings with the launch of the Weight Engage program.
5 Stocks Powering Dow ETF's 3-Month Outperformance
by Sweta Killa
The Dow Jones has been outperforming over the past three months, rising 5.8% compared with a 3.9% increase for the S&P 500.
Strength Seen in Cigna (CI): Can Its 16.7% Jump Turn into More Strength?
by Zacks Equity Research
Cigna (CI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the most recent trading session, UnitedHealth Group (UNH) closed at $543.68, indicating a -1.11% shift from the previous trading day.
UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS
by Zacks Equity Research
UnitedHealth Group's (UNH) unit has been picked up by AHCCCS to serve members of the ALTCS EPD program, which will serve as a means to further expand the health insurer's statewide footprint.
Beat the Market the Zacks Way: Shopify, Lululemon, Telos in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
UnitedHealth Group (UNH) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why You Should Retain UnitedHealth Group (UNH) Stock Now
by Zacks Equity Research
Growing membership, expanding government business, strategic acquisitions, improving operating margin and solid growth outlook poise UnitedHealth Group (UNH) well for growth.
UnitedHealth Group (UNH) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $548.28, marking a +0.2% move from the previous day.
Big Day on the Dow, +520 Points; ULTA Beats & Raises
by Mark Vickery
The Dow cleaned up this session: +520 points, +1.47%, led by Salesforce (CRM) coming off its impressive Q3 earnings report yesterday.
Analyzing Cigna & Humana Merger Talks: Opportunities & Obstacles
by Kaibalya Pravo Dey
The Cigna-Humana merger will provide the combined body with increased negotiation power with healthcare providers, pharmaceutical companies and other stakeholders.
UnitedHealth (UNH) Unveils its Latest Outlook: Key Takeaways
by Zacks Equity Research
UnitedHealth (UNH) expects the top line to be within the range of $400-$403 billion in 2024.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF